CLINICAL RESPONSE OF PATIENTS ON TOPICAL RUXOLITINIB FOR ACUTE AND CHRONIC GVHD

被引：0
|
作者：
Hudda, Zahra [1 ]
Flannery, Amanda [1 ]
Teusink-Cross, Ashley [1 ]
Khandelwal, Pooja [1 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S203 / S204
页数：2
相关论文
共 50 条
  • [31] Novel Clinical Applications of Topical Ruxolitinib: A Case Series
    Zundell, Melissa P.
    Al-Dehneem, Roudha
    Song, Teresa
    Yousif, Jenna
    Gottlieb, Alice B.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2024, 23 (03) : 188 - 190
  • [32] Corticosteroid replacement by ruxolitinib in patients with acute GVHD experiencing severe steroid-induced side effects
    de Kort, Elizabeth A.
    van Dorp, Suzanne
    Blijlevens, Nicole M. A.
    van der Velden, Walter J. F. M.
    BONE MARROW TRANSPLANTATION, 2020, 55 (01) : 253 - 255
  • [33] Photopheresis for the treatment of acute and chronic GVHD in pediatric patients.
    Dall'Amico, R
    Martini, G
    Messina, C
    Cesaro, S
    Montini, G
    Zulian, F
    Zacchello, G
    BONE MARROW TRANSPLANTATION, 1998, 21 : S84 - S84
  • [34] Acute/chronic GVHD after allogeneic transplantation in paediatric patients
    Llinares, E
    Fernández, JM
    Verdeguer, A
    Cañete, A
    Aliaga, J
    Castel, V
    BONE MARROW TRANSPLANTATION, 2002, 30 : S62 - S62
  • [35] Salvage therapy with etanercept for patients with severe acute and chronic GvHD
    Locatelli, F
    Busca, A
    Dall'Omo, A
    Sizzano, F
    Ceretto, C
    Aliberti, S
    Lovisone, E
    Falda, M
    BONE MARROW TRANSPLANTATION, 2005, 35 : S142 - S142
  • [36] Treatment of chronic GVHD - Response
    Gaziev, D
    BONE MARROW TRANSPLANTATION, 2000, 26 (04) : 461 - 462
  • [37] Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes
    Herzog, Shannon
    Weisdorf, Daniel J.
    Shanley, Ryan
    Rayes, Ahmad
    Holtan, Shernan G.
    Young, Jo-Anne
    MacMillan, Margaret L.
    El Jurdi, Najla
    BLOOD ADVANCES, 2023, 7 (14) : 3644 - 3650
  • [38] LARGE SCALE CLINICAL CHARACTERIZATION OF AUTOANTIBODIES IN PATIENTS WITH CHRONIC GVHD
    Kuzmina, Z.
    Hakim, F.
    Gounden, V.
    Rose, J.
    Cowen, E. W.
    Naik, H. B.
    Hasni, S. A.
    Mays, J.
    Curtis, L.
    Cole, K.
    Avila, D.
    Taylor, T.
    Mitchell, S.
    Baruffaldi, J.
    Baird, K.
    Steinberg, S.
    Pavletic, S. Z.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S303 - S303
  • [39] Clinical Characterization and Cytokine Profile of Fatigue in Patients with Chronic Gvhd
    Goklemez, Sencer
    Leorey, Saligan
    Pirsl, Filip
    Steinberg, Seth M.
    Mitchell, Sandra A.
    Hakim, Frances T.
    Rose, Jeremy J.
    Kang, Zhigang
    Yu, Yunkai
    Cao, Liang
    Im, Annie
    Pavletic, Steven Z.
    BLOOD, 2019, 134
  • [40] Time to first acute exacerbation can stratify the patients according to their prognosis during clinical course of chronic GvHD: evaluation of new end-point for chronic GvHD
    Sohn, SK
    Kim, DH
    Lee, KB
    Lee, KH
    Lee, JH
    Choi, SJ
    Lee, JH
    BONE MARROW TRANSPLANTATION, 2006, 37 : S82 - S82
12345